Continuous Glucose Monitor

Researchers are aiming to raise attention to the amount of waste generated with the use of diabetes devices, insulin and other treatment tools.

Once-weekly basal insulin combined with an intermittently scanned continuous glucose monitor reduced HbA1c and improved time in range for adults with type 2 diabetes, researchers reported.

The FDA has cleared a next-generation continuous glucose monitor with a 15-day sensor wear time, according to an industry press release.

Patients with type 1 diabetes initiating automated insulin delivery had a significantly lower HbA1c at 13 weeks than those receiving multiple daily insulin injections, according to a presenter.

A 15-day integrated continuous glucose monitor registered accurate glucose values similar to those measured through venous blood samples, according to a presenter.

Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of an automated insulin delivery system compared with standard care, according to findings from a new trial.

Data from the Barbara Davis Center for Diabetes at University of Colorado show pilots with type 1 diabetes are not just thriving in the air, but also with their diabetes management.

In this Healio Video Exclusive, Caroline T. Nguyen, MD, speaks with Sarit Polsky, MD, MPH, about the use of continuous glucose monitoring for pregnant women with gestational diabetes and type 1 diabetes.

Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated insulin delivery system, according to findings from the SECURE-T2D trial.

Sodium-glucose cotransporter 2, or SGLT2, inhibitors may be more cardioprotective for older adults, whereas glucagon-like peptide-1 receptor agonists may confer greater HbA1c reductions in that population, according to a systematic review and meta-analysis.